0.3597
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.3597, with a volume of 444.25K.
It is up +1.07% in the last 24 hours and down -8.08% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.3559
Open:
$0.3612
24h Volume:
444.25K
Relative Volume:
0.21
Market Cap:
$14.94M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.571
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-14.66%
1M Performance:
-8.08%
6M Performance:
+36.61%
1Y Performance:
-88.25%
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PRPH
Prophase Labs Inc
|
0.3597 | 14.78M | 62.71M | -10.48M | -13.77M | -0.63 |
![]()
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-20-21 | Initiated | H.C. Wainwright | Buy |
Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
What are ProPhase Labs Inc. company’s key revenue driversAI Powered Forecasts With Proven Results - jammulinksnews.com
Screener Results Flag ProPhase Labs Inc. as OversoldSmart Allocation Stock Pick Insights Gaining Interest - metal.it
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement - GlobeNewswire
ProPhase Labs Inc. Stock Flags Risk Zone in Volatility IndexEarly Entry Picks Before News Breakout Reviewed - metal.it
ProPhase Labs (PRPH) Seeks Shareholder Approval to Expand Share Authorization - GuruFocus
Prophase Labs Files Proxy to Increase Shares - TipRanks
ProPhase Labs Seeks 1 Billion Share Authorization to Transform from Biotech to Crypto Treasury Player - Stock Titan
Why ProPhase Labs Inc. stock attracts strong analyst attentionDaily Smart Money Movement Monitor Activated - metal.it
What makes ProPhase Labs Inc. stock price move sharplyTechnical Long-Term Outlook and Recap Guide - Newser
Will ProPhase Labs Inc. benefit from macro trendsFree Capital Preserving Trade Plan Templates - Newser
Published on: 2025-07-29 09:36:25 - metal.it
Will ProPhase Labs Inc. stock recover after recent dropDeep Learning Stock Forecast for Investors - Newser
Price Consolidation Hints at Upcoming Move in ProPhase Labs Inc.Stock Market Entry Timing Signals Revealed - beatles.ru
What are analysts’ price targets for ProPhase Labs Inc. in the next 12 monthsBest Dividend Insights For Fast Growth - jammulinksnews.com
What is the dividend policy of ProPhase Labs Inc. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Prophase Labs Secures $3M Investment Through Private Placement - TipRanks
What earnings revisions data tells us about ProPhase Labs Inc.Momentum Screener with Buy and Sell Areas - Newser
Published on: 2025-07-28 05:29:42 - Newser
Regression analysis insights on ProPhase Labs Inc. performance Free Buy Alerts With Low Risk Confirmation - Newser
What makes ProPhase Labs Inc. stock price move sharply Daily Stock Forecast Powered by AI Tools - Newser
How does ProPhase Labs Inc. generate profit in a changing economyUnmatched market performance - jammulinksnews.com
Is ProPhase Labs Inc. a growth stock or a value stockInvest with confidence backed by data - jammulinksnews.com
When is ProPhase Labs Inc. stock expected to show significant growthPowerful profit generation - jammulinksnews.com
What are the technical indicators suggesting about ProPhase Labs Inc.Get daily updates on market movers and shakers - jammulinksnews.com
How does ProPhase Labs Inc. compare to its industry peersTurn market volatility into profit opportunities - jammulinksnews.com
Why is ProPhase Labs Inc. stock attracting strong analyst attentionConsistently profitable trades - jammulinksnews.com
How volatile is ProPhase Labs Inc. stock compared to the marketCapitalize on market trends with confidence - jammulinksnews.com
Will ProPhase Labs Inc. Stock Benefit from AI and Green Energy TrendsFree Signals Group - Newser
ProPhase Labs Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree AI-Driven Trading Strategies - Newser
Bitcoin News Today: ProPhase Labs Announces Major Bitcoin Purchase as Part of Strategic Diversification Plan - AInvest
Prophase Labs shares fall 1.94% after-hours following appointment of Carolina Abenante to Audit Committee. - AInvest
What analysts say about ProPhase Labs Inc. stockDynamic investment growth - PrintWeekIndia
Prophase Labs Holds Annual Stockholders Meeting - TipRanks
ProPhase Labs Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
How ProPhase Labs Inc. stock reacts to Fed policy changesTremendous growth opportunities - jammulinksnews.com
Is ProPhase Labs Inc. a good long term investmentFree Wealth Planning Blueprint - PrintWeekIndia
Prophase Labs Secures $3 Million in Private Financing - The Globe and Mail
ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire
ProPhase Labs secures $3 million in convertible notes financing By Investing.com - Investing.com India
ProPhase Labs secures $3 million in convertible notes financing - Investing.com Australia
ProPhase Labs (PRPH) Secures $3 Million in Convertible Note Fina - GuruFocus
ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):